
ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know
Jul 31, 2026 - 26:32
Radio and PodcastLive Radio & PodcastsEditor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer Editor’s Choice: Safety and efficacy of mirvetuximab sora...
Making a difference: Molecules, mechanisms and more is an episode from Gynecologic Oncology by Health Advance. Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic...
This episode belongs to Gynecologic Oncology.
Use the player on this page to stream the episode online.
Published Nov 17, 2025, 38:54 long, audio available.